TYKERB 250 MG 70 TAB

** Tykerb 250 mg (Lapatinib Ditosylate) 70 film- coated tablet. Oral use. tyrosine kinase inhibitor, used with capecitabine for advanced / metastatic breast cancer.

** Composition:
Each film-coated tablet contains:
Lapatinib ditosylate, equivalent to 250 mg lapatinib.

** To be taken as directed by the physician.

** Do not store above 30 degrees C.
Keep out of the reach and sight of children.

** Manufactured by: Glaxo Operations UK Limited, Ware, UK (Member of the GlaxoSmithKline (GSK) group of companies)
For: Novartis Pharma AG, Basle, Switzerland

Packed by:
Glaxo Wellcome S.A., Avenida de Extremadura 3, 09400 Aranda de Duero, Burgos, Spain (Member of the GlaxoSmithKline (GSK) group of companies)
For: NOVARTIS Pharma AG, Basle, Switzerland